Stealth BioTherapeutics (MITO) Announces FDA Grants Rare Pediatric Disease Designation for Elamipretide for Treatment of Barth Syndrome

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. SPY
3. ABBV
4. IBM
5. META
6. MU
7. ACN
8. NVDA
9. FDX
10. BLZE

Go back to Stealth BioTherapeutics (MITO) Announces FDA Grants Rare Pediatric Disease Designation for Elamipretide for Treatment of Barth Syndrome

Stealth BioTherapeutics (MITO) Halted on LUDP

March 3, 2020 9:53 AM EST

Stealth BioTherapeutics (NASDAQ: MITO) Halted on LUDP

... More